Ocular Therapeutix (OCUL) Change in Cash (2013 - 2026)
Ocular Therapeutix's quarterly Change in Cash came in at -$70.4 million in Q1 2026, down 65.86% year-on-year from -$206.1 million in Q1 2025, and down 117.94% quarter-over-quarter from $392.3 million in Q4 2025.
Ocular Therapeutix has reported Change in Cash for 14 years, with the latest figure at -$70.4 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Cash fell 65.86% year-over-year to -$70.4 million; the trailing twelve-month figure through Mar 2026 stood at $317.0 million (up 337.72% YoY), and the FY2025 full-year result was $345.0 million, up 75.87% from the prior year.
- Change in Cash for Q1 2026 stood at -$70.4 million, down from $392.3 million in the prior quarter.
- The five-year high for Change in Cash was $392.3 million in Q4 2025, with the low at -$70.4 million in Q1 2026.
- Average Change in Cash over 5 years is $29.6 million, with a median of -$18.6 million recorded in 2022.
- Peak annual rise in Change in Cash reached 1333.48% in 2024, while the deepest fall reached 173.89% in 2024.
- Tracing OCUL's Change in Cash over 5 years: stood at -$18.6 million in 2022, then jumped by 557.14% to $85.3 million in 2023, then tumbled by 141.19% to -$35.1 million in 2024, then soared by 1217.06% to $392.3 million in 2025, then sank by 117.94% to -$70.4 million in 2026.
- The last three Change in Cash figures came in at -$70.4 million (Q1 2026), $392.3 million (Q4 2025), and -$46.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 623.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 417.10 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -153.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.61 Mn |
| 10 | Ocular Therapeutix | 1.99 Bn | 1.99 Bn | 9.46 Mn | -70.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -70.36 Mn |
| Dec 31, 2025 | 392.29 Mn |
| Sep 30, 2025 | -46.36 Mn |
| Jun 30, 2025 | 41.45 Mn |
| Mar 31, 2025 | -42.42 Mn |
| Dec 31, 2024 | -35.12 Mn |
| Sep 30, 2024 | -32.47 Mn |
| Jun 30, 2024 | -23.35 Mn |
| Mar 31, 2024 | 287.08 Mn |
| Dec 31, 2023 | 85.26 Mn |
| Sep 30, 2023 | 43.94 Mn |
| Jun 30, 2023 | -12.42 Mn |
| Mar 31, 2023 | -23.27 Mn |
| Dec 31, 2022 | -18.65 Mn |
| Sep 30, 2022 | -13.59 Mn |
| Jun 30, 2022 | -10.88 Mn |
| Mar 31, 2022 | -18.75 Mn |
| Dec 31, 2021 | -15.12 Mn |
| Sep 30, 2021 | -12.58 Mn |
| Jun 30, 2021 | -17.52 Mn |
| Mar 31, 2021 | -18.68 Mn |
| Dec 31, 2020 | 157.42 Mn |
| Sep 30, 2020 | -13.65 Mn |
| Jun 30, 2020 | 36.14 Mn |
| Mar 31, 2020 | -6.29 Mn |
| Dec 31, 2019 | -10.98 Mn |
| Sep 30, 2019 | -1.35 Mn |
| Jun 30, 2019 | -14.34 Mn |
| Mar 31, 2019 | 22.19 Mn |
| Dec 31, 2018 | 2.20 Mn |
| Sep 30, 2018 | 27,000.00 |
| Jun 30, 2018 | -6.08 Mn |
| Mar 31, 2018 | 21.37 Mn |
| Dec 31, 2017 | -9.74 Mn |
| Sep 30, 2017 | -11.88 Mn |
| Jun 30, 2017 | 8.37 Mn |
| Mar 31, 2017 | 21.75 Mn |
| Dec 31, 2016 | -17.80 Mn |
| Sep 30, 2016 | 4.06 Mn |
| Jun 30, 2016 | 1.96 Mn |
| Mar 31, 2016 | 15.43 Mn |
| Dec 31, 2015 | -10.41 Mn |
| Sep 30, 2015 | -37.49 Mn |
| Jun 30, 2015 | 66.16 Mn |
| Mar 31, 2015 | -24.87 Mn |
| Dec 31, 2014 | -43.50 Mn |
| Sep 30, 2014 | 60.95 Mn |
| Jun 30, 2014 | 7.19 Mn |
| Mar 31, 2014 | -4.76 Mn |
| Dec 31, 2013 | -4.11 Mn |
| Sep 30, 2013 | -3.41 Mn |